MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ABIOMED Company Profile (NASDAQ:ABMD)

Consensus Ratings for ABIOMED (NASDAQ:ABMD) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $77.00 (0.35% downside)

Analysts' Ratings History for ABIOMED (NASDAQ:ABMD)
Show:
DateFirmActionRatingPrice TargetActions
5/9/2015Jefferies GroupReiterated RatingBuy$72.00 -> $83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Leerink SwannBoost Price TargetOutperform$72.00 -> $88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Northland SecuritiesBoost Price TargetMarket Perform$40.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015BTIG ResearchReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2015Leerink SwannBoost Price TargetOutperform$60.00 -> $72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Leerink SwannBoost Price TargetOutperform$43.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015Northland SecuritiesUpgradeUnder Perform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015Jefferies GroupReiterated RatingBuy$45.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Jefferies GroupReiterated RatingBuy$37.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014BTIG ResearchDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2014Leerink SwannInitiated CoverageOutperform$34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2014BTIG ResearchUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2014BTIG ResearchInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/10/2014WunderlichBoost Price TargetBuy$29.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2013Benchmark Co.Reiterated RatingBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2013Northland SecuritiesBoost Price TargetUnderperform$9.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2013Jefferies GroupBoost Price TargetBuy$25.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2013Benchmark Co.Initiated CoverageSpeculative Buy -> Buy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha